| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444682 | European Journal of Cancer | 2013 | 10 Pages |
Abstract
Six cycles weekly paclitaxel/carboplatin followed by six 3-weekly cycles is well-tolerated and highly active in platinum-resistant and platinum-sensitive patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M.E.L. van der Burg, I. Vergote, W. Onstenk, I.A. Boere, K. Leunen, C.A.G.M. van Montfort, H.C. van Doorn,